BidaskClub Lowers Surgery Partners (SGRY) to Buy

BidaskClub cut shares of Surgery Partners (NASDAQ:SGRY) from a strong-buy rating to a buy rating in a report issued on Thursday.

A number of other equities research analysts have also recently weighed in on SGRY. ValuEngine cut shares of Surgery Partners from a hold rating to a sell rating in a report on Sunday, December 31st. Zacks Investment Research upgraded shares of Surgery Partners from a sell rating to a hold rating in a report on Saturday, January 13th. Benchmark set a $19.00 price objective on shares of Surgery Partners and gave the stock a buy rating in a report on Tuesday, January 30th. Jefferies Group set a $18.00 price objective on shares of Surgery Partners and gave the stock a buy rating in a report on Thursday, March 1st. Finally, Stifel Nicolaus dropped their target price on shares of Surgery Partners from $17.00 to $15.00 and set a sell rating on the stock in a research note on Tuesday, April 10th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $18.29.

How to Become a New Pot Stock Millionaire

Shares of SGRY opened at $16.50 on Thursday. The stock has a market capitalization of $803.31, a price-to-earnings ratio of -19.64 and a beta of 1.82. The company has a debt-to-equity ratio of 1.59, a quick ratio of 1.71 and a current ratio of 1.86. Surgery Partners has a fifty-two week low of $7.10 and a fifty-two week high of $24.05.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Thursday, March 1st. The company reported ($0.03) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.11). The business had revenue of $460.30 million during the quarter, compared to analysts’ expectations of $438.30 million. Surgery Partners had a negative return on equity of 0.53% and a negative net margin of 4.54%. Surgery Partners’s revenue for the quarter was up 50.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.35 EPS. equities analysts predict that Surgery Partners will post -0.31 earnings per share for the current year.

Hedge funds and other institutional investors have recently modified their holdings of the company. Birch Grove Capital LP lifted its stake in shares of Surgery Partners by 37.3% in the fourth quarter. Birch Grove Capital LP now owns 66,605 shares of the company’s stock worth $806,000 after buying an additional 18,100 shares in the last quarter. Royce & Associates LP lifted its stake in shares of Surgery Partners by 55.3% in the fourth quarter. Royce & Associates LP now owns 1,058,668 shares of the company’s stock worth $12,810,000 after buying an additional 377,086 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Surgery Partners by 156.0% in the third quarter. JPMorgan Chase & Co. now owns 524,775 shares of the company’s stock worth $5,379,000 after buying an additional 319,775 shares in the last quarter. Clearbridge Investments LLC lifted its stake in shares of Surgery Partners by 12.6% in the fourth quarter. Clearbridge Investments LLC now owns 2,715,434 shares of the company’s stock worth $32,857,000 after buying an additional 304,102 shares in the last quarter. Finally, Aperio Group LLC bought a new position in shares of Surgery Partners in the fourth quarter worth approximately $173,000.

COPYRIGHT VIOLATION NOTICE: “BidaskClub Lowers Surgery Partners (SGRY) to Buy” was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.chaffeybreeze.com/2018/04/16/bidaskclub-lowers-surgery-partners-sgry-to-buy.html.

Surgery Partners Company Profile

Surgery Partners, Inc is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services; Ancillary Services; and Optical Services.

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply